Anti-Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Polyclonal Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 2 publications.
View Alternative Names
NACHRA3, CHRNA3, Neuronal acetylcholine receptor subunit alpha-3
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody (AB151580)
Immunofluorescence analysis of methanol-fixed A431 cells labeling Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 with ab151580 1/500 dilution.
- WB
Unknown
Western blot - Anti-Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody (AB151580)
7.5% SDS PAGE
All lanes:
Western blot - Anti-Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody (ab151580) at 1/1000 dilution
All lanes:
Molt-4 cell lysate at 30 µg
Predicted band size: 57 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CHRNA3 serves as a critical element of neurotransmission playing a part in the nicotine-induced dopaminergic signaling pathways. Often forming a complex with other subunits like beta-2 and beta-4 it modulates synaptic plasticity and influences behavioral processes such as addiction and attention. This subunit composition affects receptor specificity and sensitivity determining how neurons respond to acetylcholine and nicotine.
Pathways
The involvement of CHRNA3 in cholinergic signaling pathways is significant. It contributes to the role of nicotinic acetylcholine receptors in the addictive properties of substances like nicotine. Interaction with proteins such as CHRNB2 (nicotinic acetylcholine receptor beta-2 subunit) exemplifies how CHRNA3 participates in modulating synaptic strength and integration in the central nervous system. Its regulatory activity in these pathways demonstrates its importance in maintaining the balance of neurotransmitter systems.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Oncotarget 14:485-501 PubMed37204253
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36012367
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com